-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Nurix Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2019 to Q1 2025.
- Nurix Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending February 28, 2025 was -$56.4M, a 35.7% decline year-over-year.
- Nurix Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending February 28, 2025 was -$208M, a 44% decline year-over-year.
- Nurix Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2024 was -$194M, a 34.5% decline from 2023.
- Nurix Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$144M, a 20.2% increase from 2022.
- Nurix Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$180M, a 53.9% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)